Author: Lynne Taylor

US Senate health bill: a mixed bag for pharma

The final version of US Senate Committee chairman Max Baucus’ long-awaited health reform bill, unveiled yesterday, maintains his earlier proposal for an annual $2.3 billion flat fee on the drug industry and would set up a medicines effectiveness comparison board.

Read More